Abstract:Abstract Introduction: ICB (immune checkpoint blocking) has been a promising therapy in cancer treatment, but there are still some patients do not response to this therapy. And it is well known that the majority cells reactivated to ICB are TCF1+ precursor exhausted T cells. Thus, studying the formation and heterogeneity of exhausted T cells are very necessary for improving the efficacy of ICB therapy. In this research, we identified a new population as TCF19+PD1+TIM3+ exhausted CD8+ T cells, which blocked the responds to ICB therapy. Methods: We collected single cell sequencing data, including colorectal cancer, gastric cancer, melanoma, and lung cancer, and drew tumor immune cells map through cluster analysis. Then using bioinformatics tools CytoTRACE. T and CCAT. A to calculate the differentiation of exhausted T cell populations, which discovered a new subset of highly proliferative and poorly differentiated terminal exhausted T cells. Subsequently, the existence of this group of cells was verified through in vitro experiments, and their formation mechanism and correlation with immunotherapy were further studied. Results: We utilized CytoTRACE.T and CCAT.A to predict differentiation states of terminally exhausted T cells. Then GEO and KEGG pathway gene set enrichment analysis were used. After analyzing, we found out that there was a subset of cells in terminally exhausted T cells defined as TCF19+PD1+TIM3+ Tex cells, which presented low differentiated and high proliferative potential.Then we performed multiple immunofluorescence staining and flow cytometry to verified the existence of TCF19+PD1+TIM3+ Tex cells in vitro. Clarifing the generation of these cell subset through regulating the expression of E2F and MYC transcription factor families.By collecting pathological sections of patients with immunotherapy information, we found that the amount of TCF19+PD1+TIM3+ Tex cells was inversely proportional to the efficacy of ICB, through immunofluorescence staining and immunohistochemical analysis as well as organoid models cocultured with T cells. Conclusion: In this research, we found a new subpopulation of terminal Tex cells, which showed high proliferation and low differentiation. For cells, TCF19 mediated the generation of stemness terminal Tex cells may through regulating the expression of E2F and MYC. Finally, we discovered that the existence of TCF19+PD1+TIM3+ Tex cells can predict the efficacy of ICB, that the more TCF19+PD1+TIM3+ Tex cells contained, the less efficacy of ICB in patients.This finding may provide a new research direction for immunotherapy. Thus, more attention should be paid to this new cell subset. Citation Format: Fuhui Wang, Nan Dong, Changhua Zhang. A new mechanism of tumor immune escape: TCF19 promotes the development of novel terminally exhausted T cells through E2F and MYC transcription family [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 66.

Divergent clonal differentiation trajectories of T cell exhaustion

Developmental relationships of four exhausted CD8 T cell subsets reveals underlying transcriptional and epigenetic control mechanisms

Longitudinal single cell transcriptional and epigenetic mapping of effector, memory, and exhausted CD8 T cells reveals shared biological circuits across distinct cell fates

Cellular and molecular waypoints along the path of T cell exhaustion

Prioritizing exhausted T cell marker genes highlights immune subtypes in pan-cancer

TET2 controls differentiation of terminally exhausted CD8 T cells

Shared and distinct biological circuits in effector, memory and exhausted CD8 + T cells revealed by temporal single-cell transcriptomics and epigenetics

The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer

Analysis of Single‐cell RNAseq Identifies Transitional States of T Cells Associated with Hepatocellular Carcinoma

Molecular and cellular insights into T cell exhaustion

Reprogramming of exhausted T cells following elimination of chronic antigen exposure

The current state and future of T-cell exhaustion research

Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation

Abstract 66: A new mechanism of tumor immune escape: TCF19 promotes the development of novel terminally exhausted T cells through E2F and MYC transcription family

Selective control of transposable element expression during T cell exhaustion and anti–PD-1 treatment

Γδ T Cell Exhaustion: Opportunities for Intervention

Application of ATAC-seq in tumor-specific T cell exhaustion

Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade

gamma delta T cell exhaustion: Opportunities for intervention

A Multi-Omics Analysis of an Exhausted T Cells' Molecular Signature in Pan-Cancer

Antigen presentation by tumor-associated macrophages drives tumor-infiltrating T cells from a progenitor exhaustion state to terminal exhaustion